[
  {
    "title": "长春高新(000661.SZ)：子公司注射用醋酸西曲瑞克获批",
    "href": "http://stock.jrj.com.cn/2022/12/08163337198447.shtml",
    "datetime": "2022-12-08 16:33:20",
    "code": "000661"
  },
  {
    "title": "天风证券点评长春高新：三季度业绩符合预期，长效产品占比进一步提升，维持“买入”评级",
    "href": "http://stock.jrj.com.cn/2022/11/08082937119073.shtml",
    "datetime": "2022-11-08 08:29:57",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：179.2015万张“高新定转”将解锁",
    "href": "http://stock.jrj.com.cn/2022/11/02194137107700.shtml",
    "datetime": "2022-11-02 19:41:56",
    "code": "000661"
  },
  {
    "title": "长春高新：大股东减持的传闻不属实",
    "href": "http://stock.jrj.com.cn/2022/11/01134937102815.shtml",
    "datetime": "2022-11-01 13:49:27",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：2378.3876万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2022/10/31174837100382.shtml",
    "datetime": "2022-10-31 17:48:03",
    "code": "000661"
  },
  {
    "title": "长春高新前三季归母净利增10% 社保基金减持近55万股",
    "href": "http://stock.jrj.com.cn/2022/10/28140637093420.shtml",
    "datetime": "2022-10-28 14:06:00",
    "code": "000661"
  },
  {
    "title": "长春高新2022年前三季度净利34.65亿同比增长10.09% 核心医药企业收入增长",
    "href": "http://stock.jrj.com.cn/2022/10/27191237090743.shtml",
    "datetime": "2022-10-27 19:12:07",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：第三季度净利13.45亿元，同比增长9.89%",
    "href": "http://stock.jrj.com.cn/2022/10/27160837089666.shtml",
    "datetime": "2022-10-27 16:08:45",
    "code": "000661"
  },
  {
    "title": "【龙虎榜】长春高新10月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/10/14180237056725.shtml",
    "datetime": "2022-10-14 18:02:41",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：百克生物的天然全人源抗狂犬病毒单克隆抗体CBB1注射液临床试验申请获批",
    "href": "http://stock.jrj.com.cn/2022/10/10154837043796.shtml",
    "datetime": "2022-10-10 15:48:07",
    "code": "000661"
  },
  {
    "title": "长春高新：全资子公司收《药品补充申请批准通知书》",
    "href": "http://stock.jrj.com.cn/2022/10/09192137042184.shtml",
    "datetime": "2022-10-09 19:21:01",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：地诺孕素片的药品上市许可持有人变更为北京金赛增",
    "href": "http://stock.jrj.com.cn/2022/10/09182037042043.shtml",
    "datetime": "2022-10-09 18:20:25",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：注射用人生长激素获批新增适应症",
    "href": "http://stock.jrj.com.cn/2022/09/29185137031845.shtml",
    "datetime": "2022-09-29 18:51:28",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：子公司EG017片获批临床试验",
    "href": "http://stock.jrj.com.cn/2022/09/21183837011860.shtml",
    "datetime": "2022-09-21 18:38:51",
    "code": "000661"
  },
  {
    "title": "主力资金上周净流出321.96亿元，光伏、地产、工程建设等受追捧，中远海控、长春高新、温氏股份等遭抛售",
    "href": "http://stock.jrj.com.cn/2022/09/12084336989024.shtml",
    "datetime": "2022-09-12 08:43:39",
    "code": "000661"
  },
  {
    "title": "长春高新：重组人生长激素产品列入福建药品集采名单 公司将充分合理制订应对预案",
    "href": "http://stock.jrj.com.cn/2022/09/07152636980070.shtml",
    "datetime": "2022-09-07 15:26:43",
    "code": "000661"
  },
  {
    "title": "一则突发消息，\"东北药茅\"瞬间飙升，半年报出炉，净利同比增10.21%",
    "href": "http://stock.jrj.com.cn/2022/08/25171836936081.shtml",
    "datetime": "2022-08-25 17:18:11",
    "code": "000661"
  },
  {
    "title": "长春高新：上半年净利润21.2亿元 同比增长10.21%",
    "href": "http://stock.jrj.com.cn/2022/08/25170336936007.shtml",
    "datetime": "2022-08-25 17:03:16",
    "code": "000661"
  },
  {
    "title": "长春高新集采惊雷四机构狂卖4亿 生长素贡献超90%净利业绩暴利难持续",
    "href": "http://stock.jrj.com.cn/2022/08/22102936920403.shtml",
    "datetime": "2022-08-22 10:29:10",
    "code": "000661"
  },
  {
    "title": "集采之下，长春高新何去何从？",
    "href": "http://stock.jrj.com.cn/2022/08/21075036919160.shtml",
    "datetime": "2022-08-21 07:50:45",
    "code": "000661"
  },
  {
    "title": "长春高新大跌启示录",
    "href": "http://stock.jrj.com.cn/2022/08/19202436917772.shtml",
    "datetime": "2022-08-19 20:24:45",
    "code": "000661"
  },
  {
    "title": "两天内市值蒸发125亿！“东北药茅”再遭“集采”重锤，16万股民心碎，平均每人亏近7.2万元",
    "href": "http://stock.jrj.com.cn/2022/08/19192436917502.shtml",
    "datetime": "2022-08-19 19:24:05",
    "code": "000661"
  },
  {
    "title": "长春高新回应：网传董秘朋友圈截图不实 目前市场情绪不理性",
    "href": "http://stock.jrj.com.cn/2022/08/19162336916244.shtml",
    "datetime": "2022-08-19 16:23:34",
    "code": "000661"
  },
  {
    "title": "长春高新：子公司GS3-007a口服液获批临床试验",
    "href": "http://stock.jrj.com.cn/2022/08/19145936916077.shtml",
    "datetime": "2022-08-19 14:59:06",
    "code": "000661"
  },
  {
    "title": "长春高新拉升 跌幅收窄至2%以内",
    "href": "http://stock.jrj.com.cn/2022/08/19135736915642.shtml",
    "datetime": "2022-08-19 13:57:10",
    "code": "000661"
  },
  {
    "title": "一度跌停！医药大白马两天急跌18%，午间紧急发布利好！“鳗鱼王”涨停，业绩增长农牧概念股出炉",
    "href": "http://stock.jrj.com.cn/2022/08/19131036915551.shtml",
    "datetime": "2022-08-19 13:10:25",
    "code": "000661"
  },
  {
    "title": "长春高新：控股子公司GS3-007a口服液获得药物临床试验批准",
    "href": "http://stock.jrj.com.cn/2022/08/19115336915424.shtml",
    "datetime": "2022-08-19 11:53:37",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：子公司GS3-007a口服液获得药物临床试验批准",
    "href": "http://stock.jrj.com.cn/2022/08/19114736915404.shtml",
    "datetime": "2022-08-19 11:47:28",
    "code": "000661"
  },
  {
    "title": "长春高新股价再度触及跌停 成交额超20亿元",
    "href": "http://stock.jrj.com.cn/2022/08/19094736914852.shtml",
    "datetime": "2022-08-19 09:47:37",
    "code": "000661"
  },
  {
    "title": "集采传闻影响继续发酵 长春高新(000661.SZ)再度逼近跌停",
    "href": "http://stock.jrj.com.cn/2022/08/19094236914857.shtml",
    "datetime": "2022-08-19 09:42:48",
    "code": "000661"
  },
  {
    "title": "商务部回应美方出台《芯片和科学法案》，长春高新回应浙江集采…重要消息还有这些",
    "href": "http://stock.jrj.com.cn/2022/08/19083236914573.shtml",
    "datetime": "2022-08-19 08:32:50",
    "code": "000661"
  },
  {
    "title": "传闻惹祸？医药龙头突然闪崩跌停，公司紧急回应！影响有多大？",
    "href": "http://stock.jrj.com.cn/2022/08/19082036914545.shtml",
    "datetime": "2022-08-19 08:20:40",
    "code": "000661"
  },
  {
    "title": "三大指数收跌，机构出逃长春高新",
    "href": "http://stock.jrj.com.cn/invest/2022/08/19074636914397.shtml",
    "datetime": "2022-08-19 07:46:20",
    "code": "000661"
  },
  {
    "title": "【龙虎榜】长春高新8月18日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/08/18180236912798.shtml",
    "datetime": "2022-08-18 18:02:41",
    "code": "000661"
  },
  {
    "title": "长春高新跌停 四机构合计卖出4.05亿元",
    "href": "http://stock.jrj.com.cn/2022/08/18174036912559.shtml",
    "datetime": "2022-08-18 17:40:29",
    "code": "000661"
  },
  {
    "title": "长春高新内部人士回应：浙江集采还没正式启动 去年广东集采对公司经营影响不大",
    "href": "http://stock.jrj.com.cn/2022/08/18173636912485.shtml",
    "datetime": "2022-08-18 17:36:42",
    "code": "000661"
  },
  {
    "title": "长春高新：从目前已有的广东联盟集采来看 未对公司生长激素产品销售产生负面影响",
    "href": "http://stock.jrj.com.cn/2022/08/18173236912458.shtml",
    "datetime": "2022-08-18 17:32:01",
    "code": "000661"
  },
  {
    "title": "长春高新内部人士回应：浙江集采还没正式启动 去年广东集采对公司经营影响不大",
    "href": "http://stock.jrj.com.cn/2022/08/18170136912275.shtml",
    "datetime": "2022-08-18 17:01:48",
    "code": "000661"
  },
  {
    "title": "长春高新回应浙江生长激素集采：政策细节仍不清晰",
    "href": "http://stock.jrj.com.cn/2022/08/18164636912160.shtml",
    "datetime": "2022-08-18 16:46:55",
    "code": "000661"
  },
  {
    "title": "长春高新午后跳水跌停，成交额超22亿元",
    "href": "http://stock.jrj.com.cn/2022/08/18142736911641.shtml",
    "datetime": "2022-08-18 14:27:40",
    "code": "000661"
  },
  {
    "title": "长春高新午后跳水逼近跌停，成交额超20亿元",
    "href": "http://stock.jrj.com.cn/2022/08/18142536911639.shtml",
    "datetime": "2022-08-18 14:25:46",
    "code": "000661"
  },
  {
    "title": "长春高新：控股子公司重组人生长激素注射液新适应症获得《药品注册证书》",
    "href": "http://stock.jrj.com.cn/2022/08/12181536896087.shtml",
    "datetime": "2022-08-12 18:15:35",
    "code": "000661"
  },
  {
    "title": "长春高新：重组人生长激素注射液增加适应症获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/08/12154636895063.shtml",
    "datetime": "2022-08-12 15:46:02",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：子公司重组人生长激素注射液增加适应症获批",
    "href": "http://stock.jrj.com.cn/2022/08/12154336895110.shtml",
    "datetime": "2022-08-12 15:43:22",
    "code": "000661"
  },
  {
    "title": "三机构席位买入长春高新",
    "href": "http://stock.jrj.com.cn/hotstock/2022/08/08084136877539.shtml",
    "datetime": "2022-08-08 08:41:15",
    "code": "000661"
  },
  {
    "title": "【龙虎榜】长春高新8月5日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/08/05180536874431.shtml",
    "datetime": "2022-08-05 18:05:03",
    "code": "000661"
  },
  {
    "title": "A股异动 | 长春高新涨4.5% 获重组人生长激素注射液相关药品批准证明文件",
    "href": "http://stock.jrj.com.cn/2022/08/05094736872704.shtml",
    "datetime": "2022-08-05 09:47:43",
    "code": "000661"
  },
  {
    "title": "长春高新：国家药监局已签发金赛药业重组人生长激素注射液相关药品批准证明文件",
    "href": "http://stock.jrj.com.cn/2022/08/04164236870437.shtml",
    "datetime": "2022-08-04 16:42:57",
    "code": "000661"
  },
  {
    "title": "长春高新：子公司已获重组人生长激素注射液相关药品批准证明文件",
    "href": "http://stock.jrj.com.cn/2022/08/04163236870415.shtml",
    "datetime": "2022-08-04 16:32:59",
    "code": "000661"
  },
  {
    "title": "长春高新：国家药监局已签发子公司重组人生长激素注射液相关药品批准证明文件",
    "href": "http://stock.jrj.com.cn/2022/08/04155036870243.shtml",
    "datetime": "2022-08-04 15:50:14",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：金赛药业重组人生长激素注射液药品批准证明文件获签发",
    "href": "http://stock.jrj.com.cn/2022/08/04154736870230.shtml",
    "datetime": "2022-08-04 15:47:26",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：EG017软膏获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/07/26183936844408.shtml",
    "datetime": "2022-07-26 18:39:51",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：向激励对象授予228.67万股限制性股票、109.86万份股票期权",
    "href": "http://stock.jrj.com.cn/2022/07/25205336841328.shtml",
    "datetime": "2022-07-25 20:53:15",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：2022年限制性股票与股票期权激励计划获得长春新区国资委批复",
    "href": "http://stock.jrj.com.cn/2022/07/19160936825152.shtml",
    "datetime": "2022-07-19 16:09:30",
    "code": "000661"
  },
  {
    "title": "中泰证券点评长春高新：金赛药业激励计划落地，长期发展进一步确定",
    "href": "http://stock.jrj.com.cn/hotstock/2022/07/12085536802308.shtml",
    "datetime": "2022-07-12 08:55:41",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：拟推404万股的2022年限制性股票与股票期权激励计划",
    "href": "http://stock.jrj.com.cn/2022/07/08204336795826.shtml",
    "datetime": "2022-07-08 20:43:27",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：重组人生长激素注射液增加适应症获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/07/06192636788091.shtml",
    "datetime": "2022-07-06 19:26:17",
    "code": "000661"
  },
  {
    "title": "【龙虎榜】长春高新6月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/06/17180636738737.shtml",
    "datetime": "2022-06-17 18:06:34",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：子公司注射用金纳单抗获美国FDA药物临床试验批准",
    "href": "http://stock.jrj.com.cn/2022/06/14153936727562.shtml",
    "datetime": "2022-06-14 15:39:21",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)2021年度权益分派10派8元 股权登记日为6月8日",
    "href": "http://stock.jrj.com.cn/2022/05/31184236694136.shtml",
    "datetime": "2022-05-31 18:42:12",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：第一大股东更名为“长春超达投资集团有限公司”",
    "href": "http://stock.jrj.com.cn/2022/05/12171636643252.shtml",
    "datetime": "2022-05-12 17:16:27",
    "code": "000661"
  },
  {
    "title": "长春高新2022年第一季度净利11.38亿同比增长30.16% 金赛药业销售收入增加",
    "href": "http://stock.jrj.com.cn/2022/05/04161136556956.shtml",
    "datetime": "2022-05-04 16:11:39",
    "code": "000661"
  },
  {
    "title": "长春高新：一季度归母净利润11.38亿元，同比增长30%",
    "href": "http://stock.jrj.com.cn/2022/04/28140236492085.shtml",
    "datetime": "2022-04-28 14:02:44",
    "code": "000661"
  },
  {
    "title": "A股异动 | 长春高新(000661.SZ)涨逾5% 一季度净利润11.38亿元 同比增长30.16%",
    "href": "http://stock.jrj.com.cn/2022/04/28101236490944.shtml",
    "datetime": "2022-04-28 10:12:43",
    "code": "000661"
  },
  {
    "title": "长春高新：一季度净利润同比增长30.16%",
    "href": "http://stock.jrj.com.cn/2022/04/27161936484415.shtml",
    "datetime": "2022-04-27 16:19:26",
    "code": "000661"
  },
  {
    "title": "长春高新经营情况正常，董秘“怒吼问天“是因为股价吗？",
    "href": "http://stock.jrj.com.cn/2022/04/25213436468335.shtml",
    "datetime": "2022-04-25 21:34:10",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：金赛药业重组人生长激素注射液等相关补充申请获批",
    "href": "http://stock.jrj.com.cn/2022/04/22114636427248.shtml",
    "datetime": "2022-04-22 11:46:32",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：利斯的明透皮贴剂的境外生产药品注册上市许可申请已获受理",
    "href": "http://stock.jrj.com.cn/2022/04/12192336316710.shtml",
    "datetime": "2022-04-12 19:23:54",
    "code": "000661"
  },
  {
    "title": "东吴证券点评长春高新：产品注册取得突破 市场空间持续拓展",
    "href": "http://stock.jrj.com.cn/hotstock/2022/04/08085736270882.shtml",
    "datetime": "2022-04-08 08:57:27",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：百克生物带状疱疹减毒活疫苗上市许可申请获受理",
    "href": "http://stock.jrj.com.cn/2022/04/06164436263069.shtml",
    "datetime": "2022-04-06 16:44:56",
    "code": "000661"
  },
  {
    "title": "方正证券点评长春高新：生长激素集采靴子落地，产品线持续丰富",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/22082634859077.shtml",
    "datetime": "2022-03-22 08:26:54",
    "code": "000661"
  },
  {
    "title": "“踩雷”之后抱团自救？易方达旗下产品集体加仓长春高新",
    "href": "http://stock.jrj.com.cn/2022/03/21080134853815.shtml",
    "datetime": "2022-03-21 08:01:50",
    "code": "000661"
  },
  {
    "title": "【机构去哪儿】超两百家机构调研格林美、长春高新；这一板块连续两周成为调研热度最高的行业",
    "href": "http://stock.jrj.com.cn/2022/03/20131334851816.shtml",
    "datetime": "2022-03-20 13:13:20",
    "code": "000661"
  },
  {
    "title": "长春高新2021年净利37.57亿同比增长23.33% 董事长马骥薪酬223.2万",
    "href": "http://stock.jrj.com.cn/2022/03/16221534836181.shtml",
    "datetime": "2022-03-16 22:15:47",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：决定向长春新区红十字基金会捐款500万元",
    "href": "http://stock.jrj.com.cn/2022/03/16204134835818.shtml",
    "datetime": "2022-03-16 20:41:14",
    "code": "000661"
  },
  {
    "title": "长春高新：2021年净利同比增23.33% 拟10派8元",
    "href": "http://stock.jrj.com.cn/2022/03/16203734835797.shtml",
    "datetime": "2022-03-16 20:37:14",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)2021年度净利润升23.33%至37.57亿元 拟10派8元",
    "href": "http://stock.jrj.com.cn/2022/03/16203434835793.shtml",
    "datetime": "2022-03-16 20:34:54",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：控股子公司亮丙瑞林注射乳剂获得药物临床试验批准",
    "href": "http://stock.jrj.com.cn/2022/03/14202434825709.shtml",
    "datetime": "2022-03-14 20:24:59",
    "code": "000661"
  },
  {
    "title": "辅助生殖概念再度活跃，长江健康6连板，长春高新等走高",
    "href": "http://stock.jrj.com.cn/2022/03/11112234812936.shtml",
    "datetime": "2022-03-11 11:22:25",
    "code": "000661"
  },
  {
    "title": "【龙虎榜】长春高新3月10日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/10180134810023.shtml",
    "datetime": "2022-03-10 18:01:22",
    "code": "000661"
  },
  {
    "title": "长春高新龙虎榜：机构净卖出8189.78万元",
    "href": "http://stock.jrj.com.cn/2022/03/10172834809865.shtml",
    "datetime": "2022-03-10 17:28:00",
    "code": "000661"
  },
  {
    "title": "长春高新：目前广东联盟采购不涉及公司长效生长激素产品",
    "href": "http://stock.jrj.com.cn/2022/01/28142434242448.shtml",
    "datetime": "2022-01-28 14:24:40",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)直线拉升一度涨超8%",
    "href": "http://stock.jrj.com.cn/2022/01/28141934242436.shtml",
    "datetime": "2022-01-28 14:19:37",
    "code": "000661"
  },
  {
    "title": "长春高新回购加董监高增持股价仍跌逾30% 公开回应称集采影响程度尚未确定",
    "href": "http://stock.jrj.com.cn/2022/01/25144634210058.shtml",
    "datetime": "2022-01-25 14:46:22",
    "code": "000661"
  },
  {
    "title": "长春高新打开跌停板 重仓基金受拖累",
    "href": "http://stock.jrj.com.cn/2022/01/25090534208340.shtml",
    "datetime": "2022-01-25 09:05:53",
    "code": "000661"
  },
  {
    "title": "长春高新职工代表监事李姝增持4000股 耗资68.78万 2021年第三季度公司净利12.24亿",
    "href": "http://stock.jrj.com.cn/2022/01/24221234206820.shtml",
    "datetime": "2022-01-24 22:12:13",
    "code": "000661"
  },
  {
    "title": "“东北茅”长春高新又出大事！大股东质押股面临爆仓？公司紧急回应…",
    "href": "http://stock.jrj.com.cn/2022/01/24174234205179.shtml",
    "datetime": "2022-01-24 17:42:46",
    "code": "000661"
  },
  {
    "title": "“东北茅”又出大事！大股东质押股面临爆仓？公司紧急回应…",
    "href": "http://stock.jrj.com.cn/2022/01/24173134205066.shtml",
    "datetime": "2022-01-24 17:31:10",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：职工代表监事李姝今日增持4000股",
    "href": "http://stock.jrj.com.cn/2022/01/24164734204758.shtml",
    "datetime": "2022-01-24 16:47:25",
    "code": "000661"
  },
  {
    "title": "连续4日跌停！长春高新大股东已有1100万股质押股权到达平仓线",
    "href": "http://stock.jrj.com.cn/2022/01/24120034203432.shtml",
    "datetime": "2022-01-24 12:00:45",
    "code": "000661"
  },
  {
    "title": "A股异动丨长春高新(000661.SZ)低开6.64% 此前连续3日跌停",
    "href": "http://stock.jrj.com.cn/2022/01/24093034199811.shtml",
    "datetime": "2022-01-24 09:30:24",
    "code": "000661"
  },
  {
    "title": "开盘：A股三大指数集体低开沪指跌0.41%，九安医疗跌停，长春高新跌超6%",
    "href": "http://stock.jrj.com.cn/2022/01/24092834199797.shtml",
    "datetime": "2022-01-24 09:28:18",
    "code": "000661"
  },
  {
    "title": "周末上市公司晚间重要公告",
    "href": "http://stock.jrj.com.cn/2022/01/23200334194793.shtml",
    "datetime": "2022-01-23 20:03:17",
    "code": "000661"
  },
  {
    "title": "长春高新：集采对公司影响和影响程度尚未确定",
    "href": "http://stock.jrj.com.cn/2022/01/23160734194230.shtml",
    "datetime": "2022-01-23 16:07:35",
    "code": "000661"
  },
  {
    "title": "长春高新董监高合计增持8.47万股 耗资约1561.53万 2021年第三季度公司净利12.24亿",
    "href": "http://stock.jrj.com.cn/2022/01/21185134183729.shtml",
    "datetime": "2022-01-21 18:51:31",
    "code": "000661"
  },
  {
    "title": "【龙虎榜】长春高新1月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/21180234183433.shtml",
    "datetime": "2022-01-21 18:02:34",
    "code": "000661"
  },
  {
    "title": "长春高新连续三日跌停 一机构卖出9467万元",
    "href": "http://stock.jrj.com.cn/2022/01/21163334182675.shtml",
    "datetime": "2022-01-21 16:33:24",
    "code": "000661"
  },
  {
    "title": "长春高新连续三日跌停 机构、北向资金现分歧",
    "href": "http://stock.jrj.com.cn/2022/01/21163334182674.shtml",
    "datetime": "2022-01-21 16:33:15",
    "code": "000661"
  },
  {
    "title": "跌上微博热搜，医药基金女神栽了，“东北药茅”遭滑铁卢，“妖王之王”跌停，股神巴菲特新动向曝光！",
    "href": "http://stock.jrj.com.cn/2022/01/21162934182663.shtml",
    "datetime": "2022-01-21 16:29:05",
    "code": "000661"
  },
  {
    "title": "A股又跳水！基金跌上热搜，股民满仓满融\"东北药茅\"长春高新，爆仓巨亏260万！",
    "href": "http://stock.jrj.com.cn/2022/01/21161034182592.shtml",
    "datetime": "2022-01-21 16:10:51",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)回购计划完成 累计耗资6亿元回购0.61%股份",
    "href": "http://stock.jrj.com.cn/2022/01/21120234181991.shtml",
    "datetime": "2022-01-21 12:02:07",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)获9名董监高合计增持8.47万股",
    "href": "http://stock.jrj.com.cn/2022/01/21115734181987.shtml",
    "datetime": "2022-01-21 11:57:10",
    "code": "000661"
  },
  {
    "title": "长春高新接连受挫市值蒸发千亿 生长激素纳入集采暴利或难续",
    "href": "http://stock.jrj.com.cn/2022/01/21074134180839.shtml",
    "datetime": "2022-01-21 07:41:52",
    "code": "000661"
  },
  {
    "title": "【龙虎榜】长春高新1月20日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/20180334179242.shtml",
    "datetime": "2022-01-20 18:03:52",
    "code": "000661"
  },
  {
    "title": "长春高新连续两日跌停 生长激素纳入集采价格或下降70%",
    "href": "http://stock.jrj.com.cn/2022/01/20173334809325.shtml",
    "datetime": "2022-01-20 17:33:00",
    "code": "000661"
  },
  {
    "title": "太卷了！A股上演罕见分裂一幕，“东北药茅”一字跌停，股民人均浮亏13万，千亿房企境外债务整体违约！",
    "href": "http://stock.jrj.com.cn/2022/01/20162234178647.shtml",
    "datetime": "2022-01-20 16:22:20",
    "code": "000661"
  },
  {
    "title": "长春高新回应股价再度跌停：目前公司日常生产经营情况正常 药品集中带量采购尚未正式开始招投标程序",
    "href": "http://stock.jrj.com.cn/2022/01/20154434178473.shtml",
    "datetime": "2022-01-20 15:44:07",
    "code": "000661"
  },
  {
    "title": "长春高新：此次药品集中带量采购尚未正式开始招投标程序 对公司的影响程度尚具有不确定性",
    "href": "http://stock.jrj.com.cn/2022/01/20152134178152.shtml",
    "datetime": "2022-01-20 15:21:45",
    "code": "000661"
  },
  {
    "title": "长春高新开盘跌停",
    "href": "http://stock.jrj.com.cn/2022/01/20092934176937.shtml",
    "datetime": "2022-01-20 09:29:54",
    "code": "000661"
  },
  {
    "title": "开盘：A股三大指数小幅低开沪指跌0.05%，ST国医跌超2%，中国石油跌近4%，长春高新再度跌停",
    "href": "http://stock.jrj.com.cn/2022/01/20092834176928.shtml",
    "datetime": "2022-01-20 09:28:30",
    "code": "000661"
  },
  {
    "title": "突然跌停！千亿白马紧急回应",
    "href": "http://stock.jrj.com.cn/2022/01/20062934176386.shtml",
    "datetime": "2022-01-20 06:29:35",
    "code": "000661"
  },
  {
    "title": "“药中茅台”长春高新闪崩跌停 日内市值蒸发超百亿股价已腰斩",
    "href": "http://stock.jrj.com.cn/2022/01/19214734809338.shtml",
    "datetime": "2022-01-19 21:47:00",
    "code": "000661"
  },
  {
    "title": "长春高新跌停，葛兰关灯吃面",
    "href": "http://stock.jrj.com.cn/2022/01/19182734174986.shtml",
    "datetime": "2022-01-19 18:27:21",
    "code": "000661"
  },
  {
    "title": "【龙虎榜】长春高新1月19日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/19180334174826.shtml",
    "datetime": "2022-01-19 18:03:34",
    "code": "000661"
  },
  {
    "title": "长春高新回应“生长激素纳入集采”：正在积极研究政策规定并将合理制定方案",
    "href": "http://stock.jrj.com.cn/2022/01/19180334174823.shtml",
    "datetime": "2022-01-19 18:03:13",
    "code": "000661"
  },
  {
    "title": "长春高新：正研究集采政策并将合理制定方案 暂无具体影响的预期",
    "href": "http://stock.jrj.com.cn/2022/01/19164634174314.shtml",
    "datetime": "2022-01-19 16:46:26",
    "code": "000661"
  },
  {
    "title": "长春高新跌停 一机构卖出8869万元",
    "href": "http://stock.jrj.com.cn/2022/01/19163134174253.shtml",
    "datetime": "2022-01-19 16:31:03",
    "code": "000661"
  },
  {
    "title": "长春高新重组人生长激素被纳入广东药品集采",
    "href": "http://stock.jrj.com.cn/2022/01/19145234173854.shtml",
    "datetime": "2022-01-19 14:52:41",
    "code": "000661"
  },
  {
    "title": "惊呆！热门板块纷纷转跌，长春高新直线跌停，生长素终于纳入集采",
    "href": "http://stock.jrj.com.cn/2022/01/19120834173451.shtml",
    "datetime": "2022-01-19 12:08:48",
    "code": "000661"
  },
  {
    "title": "长春高新跳水跌停 生长激素被纳入广东药品带量集采",
    "href": "http://stock.jrj.com.cn/2022/01/19115034173398.shtml",
    "datetime": "2022-01-19 11:50:47",
    "code": "000661"
  },
  {
    "title": "长春高新跳水跌停，总市值跌破千亿关口",
    "href": "http://stock.jrj.com.cn/2022/01/19110734173211.shtml",
    "datetime": "2022-01-19 11:07:10",
    "code": "000661"
  },
  {
    "title": "长春高新：控股子公司重组人生长激素注射液新适应症补充申请获批准",
    "href": "http://stock.jrj.com.cn/2022/01/12152334149946.shtml",
    "datetime": "2022-01-12 15:23:39",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：金赛药业注射用人生长激素相关剂型增加适应症获批",
    "href": "http://stock.jrj.com.cn/2022/01/12115134149279.shtml",
    "datetime": "2022-01-12 11:51:32",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：金赛药业重组人生长激素注射液相关剂型增加适应症获批",
    "href": "http://stock.jrj.com.cn/2021/12/31115934092094.shtml",
    "datetime": "2021-12-31 11:59:45",
    "code": "000661"
  },
  {
    "title": "金赛药业加码对外投资拓宽业务结构 前三季赚30亿为长春高新贡献97%利润",
    "href": "http://stock.jrj.com.cn/2021/12/24072934056004.shtml",
    "datetime": "2021-12-24 07:29:47",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：金赛药业拟斥5203.55万元投资杭州沃维医疗获其68%股权 涉足新生儿脑发育领域",
    "href": "http://stock.jrj.com.cn/2021/12/22172034047841.shtml",
    "datetime": "2021-12-22 17:20:18",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：金赛药业获绿叶利斯的明透皮贴剂产品内地独家商业化权利",
    "href": "http://stock.jrj.com.cn/2021/12/22171334047806.shtml",
    "datetime": "2021-12-22 17:13:33",
    "code": "000661"
  },
  {
    "title": "长春高新：拟5204万元收购杭州沃维医疗68%股权",
    "href": "http://stock.jrj.com.cn/2021/12/22170834047778.shtml",
    "datetime": "2021-12-22 17:08:49",
    "code": "000661"
  },
  {
    "title": "长春高新跌4.55% 西部证券东莞证券高点唱多",
    "href": "http://stock.jrj.com.cn/2021/12/17175134031895.shtml",
    "datetime": "2021-12-17 17:51:00",
    "code": "000661"
  },
  {
    "title": "长春高新：控股子公司华康药业拟为瑞隆药业提供1000万元担保",
    "href": "http://stock.jrj.com.cn/2021/12/09175133990960.shtml",
    "datetime": "2021-12-09 17:51:46",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)12月3日首次回购23.0001万股",
    "href": "http://stock.jrj.com.cn/2021/12/03162933960308.shtml",
    "datetime": "2021-12-03 16:29:39",
    "code": "000661"
  },
  {
    "title": "长春高新将花不超6亿元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2021/11/30183233945176.shtml",
    "datetime": "2021-11-30 18:32:15",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：金赛药业重组人生长激素注射液获批新增适应症",
    "href": "http://stock.jrj.com.cn/2021/11/30115433942991.shtml",
    "datetime": "2021-11-30 11:54:07",
    "code": "000661"
  },
  {
    "title": "长春高新股东金磊增持15.4万股 耗资4588.87万 第三季度公司净利12.24亿",
    "href": "http://stock.jrj.com.cn/2021/11/26185033924584.shtml",
    "datetime": "2021-11-26 18:50:13",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：获第二大股东金磊增持15.395万股",
    "href": "http://stock.jrj.com.cn/2021/11/26161733923781.shtml",
    "datetime": "2021-11-26 16:17:47",
    "code": "000661"
  },
  {
    "title": "回购+增持！股价大跌后的长春高新欲展示信心",
    "href": "http://stock.jrj.com.cn/2021/11/25081933918203.shtml",
    "datetime": "2021-11-25 08:19:00",
    "code": "000661"
  },
  {
    "title": "长春高新股东金磊增持300股 耗资9.27万 第三季度公司净利12.24亿",
    "href": "http://stock.jrj.com.cn/2021/11/25024633915235.shtml",
    "datetime": "2021-11-25 02:46:25",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：金磊及董监高共完成增持18.36万股 耗资4997.18万元",
    "href": "http://stock.jrj.com.cn/2021/11/24115133913700.shtml",
    "datetime": "2021-11-24 11:51:03",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)高开近5% 回购+核心股东增持",
    "href": "http://stock.jrj.com.cn/2021/11/24093133913067.shtml",
    "datetime": "2021-11-24 09:31:38",
    "code": "000661"
  },
  {
    "title": "长春高新将花不超6亿元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2021/11/24054633911376.shtml",
    "datetime": "2021-11-24 05:46:11",
    "code": "000661"
  },
  {
    "title": "长春高新：拟6亿元回购股份 回购价格不超过400元/股",
    "href": "http://stock.jrj.com.cn/2021/11/23203633911192.shtml",
    "datetime": "2021-11-23 20:36:58",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：持股5%以上股东金磊11月23日增持9.13万股",
    "href": "http://stock.jrj.com.cn/2021/11/23193333910615.shtml",
    "datetime": "2021-11-23 19:33:14",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：拟6亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2021/11/23193033910602.shtml",
    "datetime": "2021-11-23 19:30:39",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：拟以7500万元参设东证高新医药产业投资基金",
    "href": "http://stock.jrj.com.cn/2021/11/15175633855309.shtml",
    "datetime": "2021-11-15 17:56:23",
    "code": "000661"
  },
  {
    "title": "20亿杀入生长激素赛道，药企收获两连板！长春高新“一哥”地位悬了？",
    "href": "http://stock.jrj.com.cn/2021/11/13153033844318.shtml",
    "datetime": "2021-11-13 15:30:15",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)获董事、总经理姜云涛增持1.02万股",
    "href": "http://stock.jrj.com.cn/2021/11/01114933796226.shtml",
    "datetime": "2021-11-01 11:49:31",
    "code": "000661"
  },
  {
    "title": "长春高新：第三季度净利润12.24亿元 同比增长28.78%",
    "href": "http://stock.jrj.com.cn/2021/10/29160933777457.shtml",
    "datetime": "2021-10-29 16:09:13",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：第三季度净利升28.78%至12.24亿元",
    "href": "http://stock.jrj.com.cn/2021/10/29155933777392.shtml",
    "datetime": "2021-10-29 15:59:56",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：金妥利珠单抗注射液获美FDA孤儿药认定",
    "href": "http://stock.jrj.com.cn/2021/10/13180433685768.shtml",
    "datetime": "2021-10-13 18:04:44",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)及百克生物与思安信终止新冠疫苗(PIV-5载体)许可合作",
    "href": "http://stock.jrj.com.cn/2021/09/27160633524052.shtml",
    "datetime": "2021-09-27 16:06:44",
    "code": "000661"
  },
  {
    "title": "百克生物(688276.SH)及长春高新终止与思安信关于新型冠状病毒疫苗(PIV-5载体)的许可合作",
    "href": "http://stock.jrj.com.cn/2021/09/27155133523979.shtml",
    "datetime": "2021-09-27 15:51:43",
    "code": "000661"
  },
  {
    "title": "A股异动 | 长春高新(000661.SZ)涨超5% 6名董监高昨日合计增持5.08万股",
    "href": "http://stock.jrj.com.cn/2021/09/24135233509618.shtml",
    "datetime": "2021-09-24 13:52:06",
    "code": "000661"
  },
  {
    "title": "长春高新第一大股东超达投资质押45.19万股 用于补充质押担保",
    "href": "http://stock.jrj.com.cn/2021/09/10185133416439.shtml",
    "datetime": "2021-09-10 18:51:35",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：第一大股东质押45.189万股",
    "href": "http://stock.jrj.com.cn/2021/09/10160633415415.shtml",
    "datetime": "2021-09-10 16:06:16",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：华康药业成为强力枇杷露的药品上市许可持有人",
    "href": "http://stock.jrj.com.cn/2021/09/10155833415368.shtml",
    "datetime": "2021-09-10 15:58:41",
    "code": "000661"
  },
  {
    "title": "社保扩大“持股池”：新进97只个股，精准减仓长春高新（附个股）",
    "href": "http://stock.jrj.com.cn/2021/09/07212233400228.shtml",
    "datetime": "2021-09-07 21:22:14",
    "code": "000661"
  },
  {
    "title": "【龙虎榜】长春高新9月2日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/09/02180233375125.shtml",
    "datetime": "2021-09-02 18:02:43",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：子公司6个药品获得药品补充申请批件",
    "href": "http://stock.jrj.com.cn/2021/09/01155333367812.shtml",
    "datetime": "2021-09-01 15:53:19",
    "code": "000661"
  },
  {
    "title": "“怎么跟家人坦白？”股民自曝加杠杆赔光百万本金，押注“东北股王”却遭遇股价腰斩",
    "href": "http://stock.jrj.com.cn/2021/08/29152933340483.shtml",
    "datetime": "2021-08-29 15:29:10",
    "code": "000661"
  },
  {
    "title": "长春高新跌4.57% 西部证券东莞证券年内高点唱多",
    "href": "http://stock.jrj.com.cn/2021/08/17173033267626.shtml",
    "datetime": "2021-08-17 17:30:00",
    "code": "000661"
  },
  {
    "title": "暴利增高针被批，长春高新发力辅助生殖，这次能赚多少？",
    "href": "http://stock.jrj.com.cn/2021/08/17084433264872.shtml",
    "datetime": "2021-08-17 08:44:05",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：子公司拟引进上海盖浦生物一种白介素-2突变体专利技术实施许可权利",
    "href": "http://stock.jrj.com.cn/2021/08/13221333251009.shtml",
    "datetime": "2021-08-13 22:13:15",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：子公司拟受让宁波熙健所拥有的EG017相关知识产权及专有权项目",
    "href": "http://stock.jrj.com.cn/2021/08/13221033250996.shtml",
    "datetime": "2021-08-13 22:10:32",
    "code": "000661"
  },
  {
    "title": "长春高新2021年半年度净利19.23亿元 同比净利增加46.85%",
    "href": "http://stock.jrj.com.cn/2021/08/13180333249750.shtml",
    "datetime": "2021-08-13 18:03:11",
    "code": "000661"
  },
  {
    "title": "长春高新：2021年半年度净利润19.23亿元 同比增46.85%",
    "href": "http://stock.jrj.com.cn/2021/08/13171633249399.shtml",
    "datetime": "2021-08-13 17:16:36",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)半年度净利润19.23亿元 同比增长46.85%",
    "href": "http://stock.jrj.com.cn/2021/08/13171333249371.shtml",
    "datetime": "2021-08-13 17:13:24",
    "code": "000661"
  },
  {
    "title": "长春高新生长激素副作用严重可致跛行 疑涉处方药违规销售",
    "href": "http://stock.jrj.com.cn/2021/08/12112133241914.shtml",
    "datetime": "2021-08-12 11:21:00",
    "code": "000661"
  },
  {
    "title": "A股异动丨长春高新(000661.SZ)反弹约4% 部分股东及高管拟以3000万-5000万增持公司股份",
    "href": "http://stock.jrj.com.cn/2021/08/09134433224992.shtml",
    "datetime": "2021-08-09 13:44:39",
    "code": "000661"
  },
  {
    "title": "中国电信申购；广东鸿图上半年净利同比增2786%；金磊等拟增持长春高新",
    "href": "http://stock.jrj.com.cn/2021/08/09081733223173.shtml",
    "datetime": "2021-08-09 08:17:50",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：持股5%以上股东及部分董监高拟增持0.3亿-0.5亿元的股份",
    "href": "http://stock.jrj.com.cn/2021/08/06190433214012.shtml",
    "datetime": "2021-08-06 19:04:13",
    "code": "000661"
  },
  {
    "title": "长春高新：部分董监高拟合计增持3000-5000万元股份",
    "href": "http://stock.jrj.com.cn/2021/08/06185533213949.shtml",
    "datetime": "2021-08-06 18:55:21",
    "code": "000661"
  },
  {
    "title": "机构争相出逃长春高新 市场向好赵老哥大举买入",
    "href": "http://stock.jrj.com.cn/2021/08/06083033210838.shtml",
    "datetime": "2021-08-06 08:30:01",
    "code": "000661"
  },
  {
    "title": "军工股大涨延续A股结构行情",
    "href": "http://stock.jrj.com.cn/invest/2021/08/06081733210808.shtml",
    "datetime": "2021-08-06 08:17:14",
    "code": "000661"
  },
  {
    "title": "长春高新“被点名”市值一天蒸发124亿 生长激素子公司两年赚47亿贡献97%净利",
    "href": "http://stock.jrj.com.cn/2021/08/06075233210756.shtml",
    "datetime": "2021-08-06 07:52:59",
    "code": "000661"
  },
  {
    "title": "新华社点名“身高焦虑”，这两家公司股价遭“重锤”！生长激素真的可怕吗？",
    "href": "http://stock.jrj.com.cn/2021/08/05202333208872.shtml",
    "datetime": "2021-08-05 20:23:42",
    "code": "000661"
  },
  {
    "title": "【龙虎榜】长春高新8月5日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/08/05180233208149.shtml",
    "datetime": "2021-08-05 18:02:51",
    "code": "000661"
  },
  {
    "title": "“生长激素滥用”遭点名压垮长春高新、安科生物股价，增高生意经还能吃香吗？",
    "href": "http://stock.jrj.com.cn/2021/08/05165533207211.shtml",
    "datetime": "2021-08-05 16:55:21",
    "code": "000661"
  },
  {
    "title": "回应生长激素滥用 长春高新(000661.SZ)打开跌停板",
    "href": "http://stock.jrj.com.cn/2021/08/05133333206372.shtml",
    "datetime": "2021-08-05 13:33:44",
    "code": "000661"
  },
  {
    "title": "长春高新回应生长激素滥用：相关产品均销售至合法医疗机构",
    "href": "http://stock.jrj.com.cn/2021/08/05133333206370.shtml",
    "datetime": "2021-08-05 13:33:10",
    "code": "000661"
  },
  {
    "title": "长春高新逼近跌停，安科生物大跌9%，新华社点名“增高针”",
    "href": "http://stock.jrj.com.cn/2021/08/05092933205440.shtml",
    "datetime": "2021-08-05 09:29:55",
    "code": "000661"
  },
  {
    "title": "长春高新跌停，安科生物跌超9%！央媒点名“增高针”乱象",
    "href": "http://stock.jrj.com.cn/2021/08/05092833205439.shtml",
    "datetime": "2021-08-05 09:28:18",
    "code": "000661"
  },
  {
    "title": "长春高新急挫40%：投资者害怕什么？",
    "href": "http://stock.jrj.com.cn/2021/07/28174733164702.shtml",
    "datetime": "2021-07-28 17:47:36",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：子公司百克生物明日登陆科创板",
    "href": "http://stock.jrj.com.cn/2021/06/24115032988640.shtml",
    "datetime": "2021-06-24 11:50:06",
    "code": "000661"
  },
  {
    "title": "长春高新：无形资产增加非常多主要系合并范围增加brillian公司所致",
    "href": "http://stock.jrj.com.cn/2021/06/24105932988316.shtml",
    "datetime": "2021-06-24 10:59:56",
    "code": "000661"
  },
  {
    "title": "长春高新董事会、监事会完成换届选举及聘任高级管理人员",
    "href": "http://stock.jrj.com.cn/2021/06/23220632985446.shtml",
    "datetime": "2021-06-23 22:06:14",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：拟使用不超15亿元闲置自有资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/06/23192932984480.shtml",
    "datetime": "2021-06-23 19:29:32",
    "code": "000661"
  },
  {
    "title": "长春高新：中期报告时间目前尚未最后确定",
    "href": "http://stock.jrj.com.cn/2021/06/23135032982482.shtml",
    "datetime": "2021-06-23 13:50:44",
    "code": "000661"
  },
  {
    "title": "长春高新：子公司瑞宙生物的肺炎项目积极推进中",
    "href": "http://stock.jrj.com.cn/2021/06/23135032982485.shtml",
    "datetime": "2021-06-23 13:50:24",
    "code": "000661"
  },
  {
    "title": "布局老年神经退行性疾病领域，长春高新子公司拟收购北京新源长青51%股份",
    "href": "http://stock.jrj.com.cn/2021/06/23111132981539.shtml",
    "datetime": "2021-06-23 11:11:16",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：金赛药业拟收购北京新源长青51%股权 快速进入老年神经退行性疾病领域",
    "href": "http://stock.jrj.com.cn/2021/06/22165632976745.shtml",
    "datetime": "2021-06-22 16:56:41",
    "code": "000661"
  },
  {
    "title": "长春高新：吉林省五星动物保健药厂股东为长春新区国有资产监督管理委员会",
    "href": "http://stock.jrj.com.cn/2021/06/22064432973009.shtml",
    "datetime": "2021-06-22 06:44:21",
    "code": "000661"
  },
  {
    "title": "长春高新：百克生物上市后仍为公司并表范围内的子公司",
    "href": "http://stock.jrj.com.cn/2021/06/21194032971061.shtml",
    "datetime": "2021-06-21 19:40:40",
    "code": "000661"
  },
  {
    "title": "长春高新：在辅助生殖领域 公司积极推进现有产品销售 并努力推进相关新产品研发、合作进度",
    "href": "http://stock.jrj.com.cn/2021/06/21192932971013.shtml",
    "datetime": "2021-06-21 19:29:15",
    "code": "000661"
  },
  {
    "title": "长春高新：PEG自产项目目前在等待监管部门对于新旧配方对比等进行的相关审批",
    "href": "http://stock.jrj.com.cn/2021/06/17224532950528.shtml",
    "datetime": "2021-06-17 22:45:54",
    "code": "000661"
  },
  {
    "title": "长春高新拟8.4亿拿下思安信新冠疫苗独家授权",
    "href": "http://stock.jrj.com.cn/2021/06/09144932899537.shtml",
    "datetime": "2021-06-09 14:49:10",
    "code": "000661"
  },
  {
    "title": "长春高新：百克生物目前在研产品有冻干人用狂犬病疫苗（Vero细胞）、带状疱疹减毒活疫苗等16个品种",
    "href": "http://stock.jrj.com.cn/2021/06/08145132893190.shtml",
    "datetime": "2021-06-08 14:51:25",
    "code": "000661"
  },
  {
    "title": "长春高新：公司2020年鼻喷流感疫苗批签发量为156.7万人份",
    "href": "http://stock.jrj.com.cn/2021/06/08143632893122.shtml",
    "datetime": "2021-06-08 14:36:56",
    "code": "000661"
  },
  {
    "title": "长春高新“入局”新冠疫苗，拟8.4亿元获得思安信独家授权",
    "href": "http://stock.jrj.com.cn/2021/06/08102132892026.shtml",
    "datetime": "2021-06-08 10:21:52",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：取得思安信新冠疫苗(PIV-5载体)等相关技术在中国独家许可权利",
    "href": "http://stock.jrj.com.cn/2021/06/07185432888188.shtml",
    "datetime": "2021-06-07 18:54:07",
    "code": "000661"
  },
  {
    "title": "长春高新：取得新冠疫苗等在许可区域内的独家许可达成合作",
    "href": "http://stock.jrj.com.cn/2021/06/07181932887742.shtml",
    "datetime": "2021-06-07 18:19:33",
    "code": "000661"
  },
  {
    "title": "5月以来逾百家机构调研19家公司 迈瑞医疗最受关注",
    "href": "http://stock.jrj.com.cn/2021/06/04073732872436.shtml",
    "datetime": "2021-06-04 07:37:43",
    "code": "000661"
  },
  {
    "title": "长春高新土储增加引质疑 公司回应：系多年前中标地块 没有加码房地产业务",
    "href": "http://stock.jrj.com.cn/2021/06/02083332861155.shtml",
    "datetime": "2021-06-02 08:33:00",
    "code": "000661"
  },
  {
    "title": "长春高新：公司除正在销售的注射用重组人促卵泡激素外 相关产品还有曲普瑞林等",
    "href": "http://stock.jrj.com.cn/2021/06/01205532859267.shtml",
    "datetime": "2021-06-01 20:55:12",
    "code": "000661"
  },
  {
    "title": "5月基金公司调研上市公司2469次，长春高新备受瞩目",
    "href": "http://stock.jrj.com.cn/2021/06/01172432857734.shtml",
    "datetime": "2021-06-01 17:24:04",
    "code": "000661"
  },
  {
    "title": "近500家机构扎堆调研这家公司！下半年布局方向更清晰了",
    "href": "http://stock.jrj.com.cn/2021/06/01122832855959.shtml",
    "datetime": "2021-06-01 12:28:35",
    "code": "000661"
  },
  {
    "title": "长春高新：目前公司经营情况良好",
    "href": "http://stock.jrj.com.cn/2021/05/31160332850065.shtml",
    "datetime": "2021-05-31 16:03:35",
    "code": "000661"
  },
  {
    "title": "高管增持未能改变股价颓势，长春高新市值六天缩水逾400亿元",
    "href": "http://stock.jrj.com.cn/2021/05/29075032838325.shtml",
    "datetime": "2021-05-29 07:50:39",
    "code": "000661"
  },
  {
    "title": "高管增持未能改变股价颓势 长春高新市值六天缩水逾400亿元",
    "href": "http://stock.jrj.com.cn/2021/05/28214032837577.shtml",
    "datetime": "2021-05-28 21:40:00",
    "code": "000661"
  },
  {
    "title": "长春高新第一大股东超达投资质押600万股 用于质押担保",
    "href": "http://stock.jrj.com.cn/2021/05/28213732837026.shtml",
    "datetime": "2021-05-28 21:37:57",
    "code": "000661"
  },
  {
    "title": "长春高新：上海健高具备相应医疗资质 同时其并非金赛药业唯一合作方",
    "href": "http://stock.jrj.com.cn/2021/05/27144432829345.shtml",
    "datetime": "2021-05-27 14:44:20",
    "code": "000661"
  },
  {
    "title": "长春高新：目前公司相关产品在国内市场仍具有一定的优势地位",
    "href": "http://stock.jrj.com.cn/2021/05/26143632822832.shtml",
    "datetime": "2021-05-26 14:36:52",
    "code": "000661"
  },
  {
    "title": "董事长增持5700万股 16省联合带量采购成压垮长春高新的一根稻草？",
    "href": "http://stock.jrj.com.cn/2021/05/26083432821386.shtml",
    "datetime": "2021-05-26 08:34:00",
    "code": "000661"
  },
  {
    "title": "罕见！一日4家公司告别A股；长春高新获董事长、监事增持；20cm涨停，易联众澄清未参加鸿蒙系统建设",
    "href": "http://stock.jrj.com.cn/2021/05/26080132820872.shtml",
    "datetime": "2021-05-26 08:01:35",
    "code": "000661"
  },
  {
    "title": "长春高新：董事长马骥、监事赵树平合计增持6800股",
    "href": "http://stock.jrj.com.cn/2021/05/26071232820737.shtml",
    "datetime": "2021-05-26 07:12:00",
    "code": "000661"
  },
  {
    "title": "长春高新2名股东合计增持6800股 耗资合计294.47万",
    "href": "http://stock.jrj.com.cn/2021/05/25185332817913.shtml",
    "datetime": "2021-05-25 18:53:51",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：2名董事及监事合计增持2.33万股",
    "href": "http://stock.jrj.com.cn/2021/05/25160432816665.shtml",
    "datetime": "2021-05-25 16:04:54",
    "code": "000661"
  },
  {
    "title": "集采传闻+股东减持 长春高新(000661.SZ)连续第二日大跌",
    "href": "http://stock.jrj.com.cn/2021/05/24141532810181.shtml",
    "datetime": "2021-05-24 14:15:48",
    "code": "000661"
  },
  {
    "title": "长春高新：经与金磊先生初步确认，减持原因系交税之后个人一些其他资金需求",
    "href": "http://stock.jrj.com.cn/2021/05/24102032805710.shtml",
    "datetime": "2021-05-24 10:20:44",
    "code": "000661"
  },
  {
    "title": "股东套现近20亿、集采传闻影响，“医药茅”长春高新闪崩跌停！",
    "href": "http://stock.jrj.com.cn/2021/05/24095932805562.shtml",
    "datetime": "2021-05-24 09:59:13",
    "code": "000661"
  },
  {
    "title": "\"东北茅\"罕见闪崩跌停，近6万股民懵了，高瓴易方达等300家机构紧急调研",
    "href": "http://stock.jrj.com.cn/2021/05/24082332805051.shtml",
    "datetime": "2021-05-24 08:23:57",
    "code": "000661"
  },
  {
    "title": "买一手长春高新有多难？",
    "href": "http://stock.jrj.com.cn/2021/05/22162132797130.shtml",
    "datetime": "2021-05-22 16:21:37",
    "code": "000661"
  },
  {
    "title": "长春高新举行投资者会议：生物药近期集采可能性不大 金磊近期不会再有减持",
    "href": "http://stock.jrj.com.cn/2021/05/21204232795038.shtml",
    "datetime": "2021-05-21 20:42:58",
    "code": "000661"
  },
  {
    "title": "2000亿“大白马”放量跌停！啥原因？",
    "href": "http://stock.jrj.com.cn/2021/05/21201732794972.shtml",
    "datetime": "2021-05-21 20:17:05",
    "code": "000661"
  },
  {
    "title": "近6万股东惊魂，“药中茅台”跌停！第二大股东打折减持19亿元，还有重磅利空传闻突袭，公司最新回应来了",
    "href": "http://stock.jrj.com.cn/2021/05/21191132794701.shtml",
    "datetime": "2021-05-21 19:11:42",
    "code": "000661"
  },
  {
    "title": "【龙虎榜】长春高新5月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/05/21180232794316.shtml",
    "datetime": "2021-05-21 18:02:23",
    "code": "000661"
  },
  {
    "title": "股东金磊通过大宗交易减持近2%，长春高新今日跌停",
    "href": "http://stock.jrj.com.cn/2021/05/21172832794051.shtml",
    "datetime": "2021-05-21 17:28:03",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：持股5%以上的金磊以大宗交易减持809.3221万股",
    "href": "http://stock.jrj.com.cn/2021/05/21165832793904.shtml",
    "datetime": "2021-05-21 16:58:57",
    "code": "000661"
  },
  {
    "title": "长春高新：近期股东金磊累计减持公司总股本的1.9997%",
    "href": "http://stock.jrj.com.cn/2021/05/21165632793894.shtml",
    "datetime": "2021-05-21 16:56:42",
    "code": "000661"
  },
  {
    "title": "市传生长激素粉针集采 安科生物、长春高新大跌",
    "href": "http://stock.jrj.com.cn/2021/05/21144132793139.shtml",
    "datetime": "2021-05-21 14:41:34",
    "code": "000661"
  },
  {
    "title": "长春高新午后放量大跌9%逼近跌停 此前惊现19亿元大宗交易",
    "href": "http://stock.jrj.com.cn/2021/05/21135332792945.shtml",
    "datetime": "2021-05-21 13:53:25",
    "code": "000661"
  },
  {
    "title": "长春高新：公司狂犬疫苗预计今年下半年可恢复生产",
    "href": "http://stock.jrj.com.cn/2021/05/13171432749032.shtml",
    "datetime": "2021-05-13 17:14:13",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：百克生物科创板IPO注册获证监会同意",
    "href": "http://stock.jrj.com.cn/2021/05/12155732742182.shtml",
    "datetime": "2021-05-12 15:57:35",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)2020年度权益分派10派8元 股权登记日为5月18日",
    "href": "http://stock.jrj.com.cn/2021/05/11174932736294.shtml",
    "datetime": "2021-05-11 17:49:23",
    "code": "000661"
  },
  {
    "title": "国金证券：长春高新业绩增长靓丽，盈利能力增强",
    "href": "http://stock.jrj.com.cn/2021/04/26085932451586.shtml",
    "datetime": "2021-04-26 08:59:02",
    "code": "000661"
  },
  {
    "title": "长春高新一季度净利增长超六成，“医药女神”葛兰大举增仓87%",
    "href": "http://stock.jrj.com.cn/2021/04/26084032451523.shtml",
    "datetime": "2021-04-26 08:40:45",
    "code": "000661"
  },
  {
    "title": "如何寻找下一个“长春高新”？",
    "href": "http://stock.jrj.com.cn/2021/04/25174532438472.shtml",
    "datetime": "2021-04-25 17:45:52",
    "code": "000661"
  },
  {
    "title": "长春高新一季度同比增加61%至8.75亿元",
    "href": "http://stock.jrj.com.cn/2021/04/25110232436947.shtml",
    "datetime": "2021-04-25 11:02:23",
    "code": "000661"
  },
  {
    "title": "长春高新2021年第一季度净利增长61.21% 下属制药公司收入增加",
    "href": "http://stock.jrj.com.cn/2021/04/24091432434581.shtml",
    "datetime": "2021-04-24 09:14:48",
    "code": "000661"
  },
  {
    "title": "大连一大妈火了！2008年花5万炒股，今天销户，竟变成500万！",
    "href": "http://stock.jrj.com.cn/2021/04/23213432432431.shtml",
    "datetime": "2021-04-23 21:34:32",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：重组人生长激素注射液新适应症补充申请获批",
    "href": "http://stock.jrj.com.cn/2021/04/23163632430521.shtml",
    "datetime": "2021-04-23 16:36:56",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)一季度净利润升61.21%至8.75亿元",
    "href": "http://stock.jrj.com.cn/2021/04/23163232430497.shtml",
    "datetime": "2021-04-23 16:32:45",
    "code": "000661"
  },
  {
    "title": "长春高新：一季度净利同比增长61.21%",
    "href": "http://stock.jrj.com.cn/2021/04/23163032430469.shtml",
    "datetime": "2021-04-23 16:30:26",
    "code": "000661"
  },
  {
    "title": "长春高新：公司根据产品市场空间、公司战略布局及研发规划等确定推进具体研发项目",
    "href": "http://stock.jrj.com.cn/2021/04/21103532414915.shtml",
    "datetime": "2021-04-21 10:35:43",
    "code": "000661"
  },
  {
    "title": "长春高新：对于员工持股等目前尚无具体计划",
    "href": "http://stock.jrj.com.cn/2021/04/20094332407891.shtml",
    "datetime": "2021-04-20 09:43:45",
    "code": "000661"
  },
  {
    "title": "A股异动 | 长春高新(000661.SZ)跌逾4% 连续5日遭北上资金净卖出，累计卖出1.72亿元",
    "href": "http://stock.jrj.com.cn/2021/04/16105332385058.shtml",
    "datetime": "2021-04-16 10:53:34",
    "code": "000661"
  },
  {
    "title": "一季度重组人生长激素收入大增 行业老二安科生物能否挑战长春高新？",
    "href": "http://stock.jrj.com.cn/2021/04/08192432333601.shtml",
    "datetime": "2021-04-08 19:24:42",
    "code": "000661"
  },
  {
    "title": "长春高新：公司生长激素产品作为处方药需准许国家相关药品宣传要求",
    "href": "http://stock.jrj.com.cn/2021/04/02095032268939.shtml",
    "datetime": "2021-04-02 09:50:34",
    "code": "000661"
  },
  {
    "title": "控股骨干医药企业收入增长，长春高新一季度盈利同比增超55%",
    "href": "http://stock.jrj.com.cn/2021/03/30105532246802.shtml",
    "datetime": "2021-03-30 10:55:59",
    "code": "000661"
  },
  {
    "title": "A股异动 | 长春高新(000661.SZ)涨逾6% 一季度预增55%-65%叠加券商看好",
    "href": "http://stock.jrj.com.cn/2021/03/30102332246604.shtml",
    "datetime": "2021-03-30 10:23:11",
    "code": "000661"
  },
  {
    "title": "长春高新一季度业绩预增五成 主业“减速”情况下今年能否再创佳绩？",
    "href": "http://stock.jrj.com.cn/2021/03/30083632246332.shtml",
    "datetime": "2021-03-30 08:36:00",
    "code": "000661"
  },
  {
    "title": "长春高新2021年第一季度预计净利增长55%-65% 控股骨干医药企业收入增长",
    "href": "http://stock.jrj.com.cn/2021/03/29204332243142.shtml",
    "datetime": "2021-03-29 20:43:23",
    "code": "000661"
  },
  {
    "title": "长春高新：一季度预盈8.41亿元-8.95亿元 同比增55%-65%",
    "href": "http://stock.jrj.com.cn/2021/03/29163432241613.shtml",
    "datetime": "2021-03-29 16:34:39",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：预计一季度净利8.41亿元-8.95亿元 同比增长55%-65%",
    "href": "http://stock.jrj.com.cn/2021/03/29162932241588.shtml",
    "datetime": "2021-03-29 16:29:45",
    "code": "000661"
  },
  {
    "title": "长春高新跌5.7% 华西证券太平洋证券年内高点喊买入",
    "href": "http://stock.jrj.com.cn/2021/03/19172532164879.shtml",
    "datetime": "2021-03-19 17:25:00",
    "code": "000661"
  },
  {
    "title": "长春高新迎来148家机构调研：子公司狂犬疫苗预计2022年恢复销售",
    "href": "http://stock.jrj.com.cn/2021/03/16152332144968.shtml",
    "datetime": "2021-03-16 15:23:52",
    "code": "000661"
  },
  {
    "title": "长春高新跌7.12% 华西证券太平洋证券高点喊买入",
    "href": "http://stock.jrj.com.cn/2021/03/15180732137837.shtml",
    "datetime": "2021-03-15 18:07:00",
    "code": "000661"
  },
  {
    "title": "长春高新2020年净利30.47亿增长71.64%水痘疫苗批签发数量增加 董事长马骥薪酬223.2万",
    "href": "http://stock.jrj.com.cn/2021/03/12200932122416.shtml",
    "datetime": "2021-03-12 20:09:18",
    "code": "000661"
  },
  {
    "title": "长春高新去年净利30亿同比增72% 今股价涨0.09%",
    "href": "http://stock.jrj.com.cn/2021/03/12152332115330.shtml",
    "datetime": "2021-03-12 15:23:00",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)2020年度净利润升71.64%至30.47亿元 拟10派8元",
    "href": "http://stock.jrj.com.cn/2021/03/11214032111113.shtml",
    "datetime": "2021-03-11 21:40:14",
    "code": "000661"
  },
  {
    "title": "长春高新年度报告：2020年度净利润同比增长71.67% 拟每10股派8元",
    "href": "http://stock.jrj.com.cn/2021/03/11213132111097.shtml",
    "datetime": "2021-03-11 21:31:41",
    "code": "000661"
  },
  {
    "title": "长春高新：目前冻干人用狂犬病疫苗（Vero细胞）处于Ⅲ期临床试验阶段",
    "href": "http://stock.jrj.com.cn/2021/03/05170532078858.shtml",
    "datetime": "2021-03-05 17:05:30",
    "code": "000661"
  },
  {
    "title": "A股异动 | 长春高新(000661.SZ)涨超4% 百克生物鼻喷流感减毒活疫苗(液体剂型)获批临试",
    "href": "http://stock.jrj.com.cn/2021/03/03150032063477.shtml",
    "datetime": "2021-03-03 15:00:19",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：百克生物鼻喷流感减毒活疫苗(液体剂型)获批临试",
    "href": "http://stock.jrj.com.cn/2021/03/03115332062890.shtml",
    "datetime": "2021-03-03 11:53:05",
    "code": "000661"
  },
  {
    "title": "长春高新：目前金赛药业生长激素产品出口部分国家",
    "href": "http://stock.jrj.com.cn/2021/01/29162331809649.shtml",
    "datetime": "2021-01-29 16:23:18",
    "code": "000661"
  },
  {
    "title": "长春高新拆分百克生物拟冲科创板 停产狂犬疫苗研发多靠\"体外\"",
    "href": "http://stock.jrj.com.cn/2021/01/26071931772704.shtml",
    "datetime": "2021-01-26 07:19:18",
    "code": "000661"
  },
  {
    "title": "长春高新：公司目前生产经营正常切实贯彻医药产业为主、房地产业为辅的产业战略",
    "href": "http://stock.jrj.com.cn/2021/01/25180331767216.shtml",
    "datetime": "2021-01-25 18:03:19",
    "code": "000661"
  },
  {
    "title": "长春高新：部分高管、董事拟合计减持不超过6.37万股",
    "href": "http://stock.jrj.com.cn/2021/01/12110831675245.shtml",
    "datetime": "2021-01-12 11:08:14",
    "code": "000661"
  },
  {
    "title": "长春高新：部分董事高管拟合计减持不超6.37万股",
    "href": "http://stock.jrj.com.cn/2021/01/11165531670834.shtml",
    "datetime": "2021-01-11 16:55:04",
    "code": "000661"
  },
  {
    "title": "一度涨逾9%！长春高新股价重回500元，业绩连升背后有何隐患",
    "href": "http://stock.jrj.com.cn/2021/01/06141731641089.shtml",
    "datetime": "2021-01-06 14:17:36",
    "code": "000661"
  },
  {
    "title": "彻底火了！“东北茅台”冲上2000亿 股价一度历史新高！业绩暴增逾70% 去年曾经历突然闪崩！",
    "href": "http://stock.jrj.com.cn/2021/01/06124131640679.shtml",
    "datetime": "2021-01-06 12:41:10",
    "code": "000661"
  },
  {
    "title": "长春高新：2020年度净利润预计为30.18亿-31.95亿",
    "href": "http://stock.jrj.com.cn/2021/01/06111831640246.shtml",
    "datetime": "2021-01-06 11:18:35",
    "code": "000661"
  },
  {
    "title": "A股异动 | 长春高新(000661.SZ)涨超9%创历史新高 市值超2100亿元",
    "href": "http://stock.jrj.com.cn/2021/01/06095231639631.shtml",
    "datetime": "2021-01-06 09:52:38",
    "code": "000661"
  },
  {
    "title": "每日“药”闻|美国新冠疫苗接种比例低于预期；长春高新净利润预计大增",
    "href": "http://stock.jrj.com.cn/2021/01/06092431644047.shtml",
    "datetime": "2021-01-06 09:24:00",
    "code": "000661"
  },
  {
    "title": "长春高新业绩预增超七成 合并子公司报表对业绩贡献大",
    "href": "http://stock.jrj.com.cn/2021/01/06082131639579.shtml",
    "datetime": "2021-01-06 08:21:00",
    "code": "000661"
  },
  {
    "title": "长春高新预计2020年净利同比增长70%~80%",
    "href": "http://stock.jrj.com.cn/2021/01/06040231637584.shtml",
    "datetime": "2021-01-06 04:02:46",
    "code": "000661"
  },
  {
    "title": "长春高新：2020年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2021/01/05213031636692.shtml",
    "datetime": "2021-01-05 21:30:00",
    "code": "000661"
  },
  {
    "title": "长春高新业绩预告：2020年度净利润同比增长70%-80%",
    "href": "http://stock.jrj.com.cn/2021/01/05203331636425.shtml",
    "datetime": "2021-01-05 20:33:43",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：2020年度净利预增70%-80%",
    "href": "http://stock.jrj.com.cn/2021/01/05203231636416.shtml",
    "datetime": "2021-01-05 20:32:21",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：477.1102万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2021/01/04214831629481.shtml",
    "datetime": "2021-01-04 21:48:08",
    "code": "000661"
  },
  {
    "title": "长春高新二股东金磊遭批评 发表减持言论影响股价跌停",
    "href": "http://stock.jrj.com.cn/2021/01/04174231627883.shtml",
    "datetime": "2021-01-04 17:42:00",
    "code": "000661"
  },
  {
    "title": "长春高新控股股东超达投资质押500万股 用于质押担保",
    "href": "http://stock.jrj.com.cn/2020/12/29193031597031.shtml",
    "datetime": "2020-12-29 19:30:46",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：第一大股东质押500万股",
    "href": "http://stock.jrj.com.cn/2020/12/29162531595750.shtml",
    "datetime": "2020-12-29 16:25:00",
    "code": "000661"
  },
  {
    "title": "生长激素企业玩“跨界”，长春高新CD47抗体在美国获批临床",
    "href": "http://stock.jrj.com.cn/2020/12/21181231538907.shtml",
    "datetime": "2020-12-21 18:12:00",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：金妥利珠单抗注射液获得美国FDA药物临床试验批准",
    "href": "http://stock.jrj.com.cn/2020/12/18192531520368.shtml",
    "datetime": "2020-12-18 19:25:45",
    "code": "000661"
  },
  {
    "title": "资深个人投资者狮子皇，谈对长春高新(000661.SZ)核心资产逻辑的再认识",
    "href": "http://stock.jrj.com.cn/2020/12/18144431518226.shtml",
    "datetime": "2020-12-18 14:44:29",
    "code": "000661"
  },
  {
    "title": "“吃药”行情又来：“东北药茅”也飙涨8% 机构火线解读",
    "href": "http://stock.jrj.com.cn/2020/12/17193131511340.shtml",
    "datetime": "2020-12-17 19:31:26",
    "code": "000661"
  },
  {
    "title": "长春高新(000661.SZ)：约1597.11万股限售股12月16日解禁",
    "href": "http://stock.jrj.com.cn/2020/12/14173131487888.shtml",
    "datetime": "2020-12-14 17:31:22",
    "code": "000661"
  },
  {
    "title": "长春高新：目前金赛药业生长激素产品出口10余个国家 未来将有计划的进入国际市场",
    "href": "http://stock.jrj.com.cn/2020/12/08161131440416.shtml",
    "datetime": "2020-12-08 16:11:37",
    "code": "000661"
  },
  {
    "title": "长春高新：公司会根据整体战略发展规划及现有优势等综合考虑发展方向",
    "href": "http://stock.jrj.com.cn/2020/12/01162831385392.shtml",
    "datetime": "2020-12-01 16:28:19",
    "code": "000661"
  },
  {
    "title": "长春高新领涨医疗制药 英飞特翻倍游资逢高抛售",
    "href": "http://stock.jrj.com.cn/2020/11/01094831183109.shtml",
    "datetime": "2020-11-01 09:48:17",
    "code": "000661"
  },
  {
    "title": "长春高新领涨医疗制药 英飞特翻倍游资逢高抛售",
    "href": "http://stock.jrj.com.cn/2020/10/31084331179569.shtml",
    "datetime": "2020-10-31 08:43:49",
    "code": "000661"
  },
  {
    "title": "鼻喷式流感疫苗或成长春高新新利润增长点",
    "href": "http://stock.jrj.com.cn/2020/10/28211431152535.shtml",
    "datetime": "2020-10-28 21:14:20",
    "code": "000661"
  },
  {
    "title": "大逆转！“东北茅台”两天暴涨近16% 大资金疯狂扫货5.5亿元",
    "href": "http://stock.jrj.com.cn/2020/10/28065731147103.shtml",
    "datetime": "2020-10-28 06:57:56",
    "code": "000661"
  },
  {
    "title": "长春高新受捧封涨停 新冠疫苗研发顺利推进",
    "href": "http://stock.jrj.com.cn/2020/10/28031831146013.shtml",
    "datetime": "2020-10-28 03:18:51",
    "code": "000661"
  },
  {
    "title": "大额买入长春高新 机构热情开始回暖",
    "href": "http://stock.jrj.com.cn/invest/2020/10/28012331145790.shtml",
    "datetime": "2020-10-28 01:23:57",
    "code": "000661"
  },
  {
    "title": "龙虎榜：长春高新涨停 获北向资金、机构资金买入",
    "href": "http://stock.jrj.com.cn/2020/10/27220731144839.shtml",
    "datetime": "2020-10-27 22:07:59",
    "code": "000661"
  },
  {
    "title": "公募+社保联合减持超300亿 这只疫苗龙头透露大消息",
    "href": "http://stock.jrj.com.cn/2020/10/27213031144567.shtml",
    "datetime": "2020-10-27 21:30:34",
    "code": "000661"
  },
  {
    "title": "“东北茅台”两天暴涨近16% 大资金今日疯狂扫货5.5亿元",
    "href": "http://stock.jrj.com.cn/2020/10/27211531144493.shtml",
    "datetime": "2020-10-27 21:15:35",
    "code": "000661"
  },
  {
    "title": "长春高新：目前生长激素二期工厂正在进行建设",
    "href": "http://stock.jrj.com.cn/2020/10/27185031143607.shtml",
    "datetime": "2020-10-27 18:50:48",
    "code": "000661"
  },
  {
    "title": "【龙虎榜】长春高新10月27日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/10/27180031143250.shtml",
    "datetime": "2020-10-27 18:00:07",
    "code": "000661"
  }
]